Representative Image
BENGALURU: The Indian drug maker Cipla Ltd., on Wednesday, July 8, said that it has priced its generic version of remdesivir, Cipremi, at Rs 4,000 per 100 mg vial, which is among the lowest globally.
Nikhil Chopra, Executive Vice-President and CEO, Cipla India, in an emailed statement said that the company was launching Cipremi commercially on Wednesday and aims to supply over 80,000 vials within the first month. He added the drug will only be available through government and hospital channels to ensure equitable distribution. As part of its efforts to help the society in this time of need, Cipla will also donate some of the medication.
Cipla’s Cipremi was authorised for restricted emergency use in the country by the Drug Controller General of India (DCGI) as part of the accelerated approval process, considering the urgent and unmet medical needs.
Representative Image GURUGRAM, Haryana: The Department of Urban Local Bodies in Haryana has decided to…
Representative Image KOHIMA, Nagaland: An official confirmed that the Government of Nagaland has approved to…
Representative Image SHILLONG, Meghalaya: The Khasi Hill Autonomous District Council (KHADC) has decided to request financial assistance for…
Representative Image CHENNAI, Tamil Nadu: Considering that the temperature is expected to spike by 3-5…
Representative Image CHENNAI, Tamil Nadu: Intending to eradicate manual cleaning, the Madras High Court has…
Representative Image NEW DELHI: The Commission for Air Quality Management (CAQM) has urged the urban…